ANTONUCCI, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 578
EU - Europa 254
AS - Asia 143
AF - Africa 7
Totale 982
Nazione #
US - Stati Uniti d'America 576
IT - Italia 116
IE - Irlanda 53
SG - Singapore 51
CN - Cina 49
SE - Svezia 37
VN - Vietnam 18
CZ - Repubblica Ceca 10
HK - Hong Kong 9
FI - Finlandia 8
KR - Corea 7
NG - Nigeria 6
UA - Ucraina 6
DE - Germania 4
IN - India 4
NL - Olanda 4
ES - Italia 3
AT - Austria 2
FR - Francia 2
RO - Romania 2
TH - Thailandia 2
BY - Bielorussia 1
CA - Canada 1
GB - Regno Unito 1
GE - Georgia 1
HN - Honduras 1
JP - Giappone 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
PL - Polonia 1
RS - Serbia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 982
Città #
Chandler 151
Dublin 53
Singapore 37
Nyköping 33
Turin 29
Fairfield 28
Torino 20
Ashburn 19
Medford 16
Princeton 16
Hangzhou 14
Brno 10
Wilmington 9
Beijing 8
Hebei 8
Houston 8
New York 8
Cambridge 7
Lappeenranta 7
Seattle 7
Seoul 7
Washington 7
Woodbridge 7
Abuja 6
Hong Kong 6
Santa Clara 6
Boston 5
Milan 5
Ann Arbor 4
Chengdu 4
Dong Ket 4
Fremont 4
Bologna 3
Guiyang 3
Jacksonville 3
Los Angeles 3
Norwalk 3
Pune 3
San Diego 3
Upper Marlboro 3
Bassano del Grappa 2
Chicago 2
Chongqing 2
Falls Church 2
Guangzhou 2
Mele 2
Munich 2
Naples 2
Noceto 2
Padova 2
Pontevedra 2
Saluzzo 2
San Mateo 2
Stockholm 2
Vienna 2
Amsterdam 1
Baricella 1
Belgrade 1
Berlin 1
Boardman 1
Bucharest 1
Cape Town 1
Casalnuovo Di Napoli 1
Changsha 1
Collegno 1
Falconara Marittima 1
Florence 1
Garden City 1
Genoa 1
Glenwood 1
Helsinki 1
Iernut 1
London 1
Madrid 1
Modena 1
Montréal 1
Mumbai 1
Nanjing 1
Novara 1
Pian Camuno 1
Piemonte 1
Rende 1
Rome 1
Senago 1
Shanghai 1
Silver Spring 1
Sioux Falls 1
Tegucigalpa 1
Tokyo 1
Vaduz 1
Warsaw 1
Totale 643
Nome #
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV 83
Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients 65
Analytical validation and clinical application of rapid serological tests for sars-cov-2 suitable for large-scale screening 62
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 61
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma 56
Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection? 53
Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient Context 50
Validation and Clinical Application of a New Liquid Chromatography Coupled to Mass Spectrometry (HPLC-MS) Method for Dalbavancin Quantification in Human Plasma 50
Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study 49
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz 48
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy 48
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients 47
Seasonal variation of antiretroviral drug exposure during the year: The experience of 10 years of therapeutic drug monitoring 46
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? 41
Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery 39
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease 38
Pregnancy and COVID-19: The Possible Contribution of Vitamin D 30
COVID-19: A Possible Contribution of the MAPK Pathway 24
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants 21
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis 20
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics 18
A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis 14
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study 11
Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality 11
Gender differences in five different drug pharmacokinetics 9
Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM 9
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease 6
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy 5
Physical activity, oxidative stress and antiretroviral therapy in people with HIV switched from triple to dual therapy: a multidisciplinary pilot study. 5
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV 4
Comparative Performance Assessment of Novel Fluorescence Immunoassay POCTs for Measuring Circulating Levels of Vitamin-D 4
Totale 1.027
Categoria #
all - tutte 5.817
article - articoli 0
book - libri 0
conference - conferenze 141
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 3 5 10 9 4 4 12 12 42
2021/2022217 11 1 14 8 31 16 9 4 6 11 63 43
2022/2023403 34 37 11 28 31 88 18 35 61 13 28 19
2023/2024259 20 40 22 16 11 26 8 6 13 19 30 48
2024/202547 17 30 0 0 0 0 0 0 0 0 0 0
Totale 1.027